EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2)

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT06148532
Status
Enrolling By Invitation

Conditions

  • Infections
  • Maternal Sepsis

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities, labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary observational study is to optimize risk prediction accounting for the social determinants of health, and establish a novel maternal care continuity model to reduce sepsis- related death and disability and increase maternal health equity.

Key Dates

Start date
Apr 26, 2023
Status verified
Jan 2026
Primary completion
Dec 9, 2025
Completion
Sep 30, 2026

Study Design

Enrollment
400,000 participants (estimated)

Arms

  • Arm: PRC Database
    EHR records for hospital delivery admissions and postpartum readmissions obtained from Perinatal Research Consortium (PRC) sites to be harmonized with SDoH data and analyze to optimize sepsis risk prediction.

Primary Outcome Measure

Maternal sepsis risk [ Time Frame: Delivery hospitalization through 8 weeks postpartum ]

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia Unviersity Medical CenterNew YorkNew York10032-

Find similar trials in New York, NY

By research site
Columbia Unviersity Medical Center· New York, NY

Related Studies